Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9536 | 1079 | 49.2 | 87% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
202 | 20434 | CLOPIDOGREL//PRASUGREL//ASPIRIN RESISTANCE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PLATELET PROTEOME | Author keyword | 11 | 78% | 1% | 7 |
2 | EFS AUVERGNE LOIRE | Address | 8 | 70% | 1% | 7 |
3 | SECT CARDIOIMMUNOL | Address | 6 | 80% | 0% | 4 |
4 | PLATELET MONOCYTE AGGREGATES | Author keyword | 6 | 53% | 1% | 8 |
5 | PLATELET MONOCYTE AGGREGATION | Author keyword | 4 | 75% | 0% | 3 |
6 | RELEASATE | Author keyword | 4 | 75% | 0% | 3 |
7 | PLATELET LEUKOCYTE INTERACTION | Author keyword | 3 | 37% | 1% | 7 |
8 | CELL BIOL PHARMACOL THROMBOSIS | Address | 3 | 45% | 0% | 5 |
9 | KLIN KARDIOL KREISLAUFERKRANKUNGEN | Address | 3 | 42% | 0% | 5 |
10 | PLATELET MONOCYTE COMPLEXES | Author keyword | 3 | 42% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PLATELET PROTEOME | 11 | 78% | 1% | 7 | Search PLATELET+PROTEOME | Search PLATELET+PROTEOME |
2 | PLATELET MONOCYTE AGGREGATES | 6 | 53% | 1% | 8 | Search PLATELET+MONOCYTE+AGGREGATES | Search PLATELET+MONOCYTE+AGGREGATES |
3 | PLATELET MONOCYTE AGGREGATION | 4 | 75% | 0% | 3 | Search PLATELET+MONOCYTE+AGGREGATION | Search PLATELET+MONOCYTE+AGGREGATION |
4 | RELEASATE | 4 | 75% | 0% | 3 | Search RELEASATE | Search RELEASATE |
5 | PLATELET LEUKOCYTE INTERACTION | 3 | 37% | 1% | 7 | Search PLATELET+LEUKOCYTE+INTERACTION | Search PLATELET+LEUKOCYTE+INTERACTION |
6 | PLATELET MONOCYTE COMPLEXES | 3 | 42% | 0% | 5 | Search PLATELET+MONOCYTE+COMPLEXES | Search PLATELET+MONOCYTE+COMPLEXES |
7 | G6F | 2 | 67% | 0% | 2 | Search G6F | Search G6F |
8 | NEUTROPHILS PLATELETS | 2 | 67% | 0% | 2 | Search NEUTROPHILS+PLATELETS | Search NEUTROPHILS+PLATELETS |
9 | PLATELET LEUKOCYTE AGGREGATES | 2 | 30% | 1% | 6 | Search PLATELET+LEUKOCYTE+AGGREGATES | Search PLATELET+LEUKOCYTE+AGGREGATES |
10 | PSGL I | 2 | 50% | 0% | 3 | Search PSGL+I | Search PSGL+I |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANUCLEATE PLATELETS | 31 | 71% | 2% | 25 |
2 | ACTIVATED PLATELETS | 31 | 15% | 18% | 197 |
3 | SURFACE ADHERENT PLATELETS | 27 | 55% | 3% | 34 |
4 | ACTIVATED HUMAN PLATELETS | 25 | 36% | 5% | 55 |
5 | LEUKOCYTE INTEGRIN MAC 1 | 13 | 34% | 3% | 31 |
6 | IMMUNE CONTINUUM | 9 | 83% | 0% | 5 |
7 | PLATELET POLYMORPHONUCLEAR LEUKOCYTE INTERACTION | 7 | 53% | 1% | 10 |
8 | ADHERENT PLATELETS | 6 | 22% | 2% | 26 |
9 | INTEGRIN CD11B CD18 | 6 | 53% | 1% | 8 |
10 | NEUTROPHIL EXTRACELLULAR TRAPS | 5 | 11% | 4% | 40 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Platelets and the immune continuum | 2011 | 267 | 93 | 35% |
Platelets as Cellular Effectors of Inflammation in Vascular Diseases | 2013 | 53 | 157 | 53% |
Platelets in inflammation and atherogenesis | 2005 | 561 | 81 | 43% |
Chronic hepatitis B: role of anti-platelet therapy in inflammation control | 2015 | 2 | 35 | 57% |
Platelets: bridging hemostasis, inflammation, and immunity | 2013 | 36 | 27 | 44% |
Emerging roles for platelets as immune and inflammatory cells | 2014 | 31 | 154 | 26% |
Platelet physiology | 2009 | 161 | 50 | 36% |
Protein synthesis by platelets: historical and new perspectives | 2009 | 71 | 47 | 64% |
Platelets as immune cells - Bridging inflammation and cardiovascular disease | 2007 | 278 | 194 | 21% |
Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum | 2012 | 36 | 247 | 44% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EFS AUVERGNE LOIRE | 8 | 70% | 0.6% | 7 |
2 | SECT CARDIOIMMUNOL | 6 | 80% | 0.4% | 4 |
3 | CELL BIOL PHARMACOL THROMBOSIS | 3 | 45% | 0.5% | 5 |
4 | KLIN KARDIOL KREISLAUFERKRANKUNGEN | 3 | 42% | 0.5% | 5 |
5 | VASC BIOL PHARMACOL | 3 | 30% | 0.6% | 7 |
6 | ETAB FRANCAIS SANG AUVERGNE LOIRE | 2 | 67% | 0.2% | 2 |
7 | FRAMINGHAM HEART | 2 | 67% | 0.2% | 2 |
8 | UNIT BIOL CELL INTERACT | 2 | 67% | 0.2% | 2 |
9 | EA3064 | 2 | 21% | 0.6% | 7 |
10 | GIM EA3064 | 2 | 20% | 0.6% | 7 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000223798 | CORONARY ARTERIAL TONE//VASC BIOL MED ERFURT//PLATELET NEUTROPHIL INTERACTION |
2 | 0.0000187644 | JOBST VASC SURG//CONRAD JOBST VASC S//SOLUBLE P SELECTIN |
3 | 0.0000131571 | PLATELET APOPTOSIS//COATED PLATELET//STUDY HUMAN OPERATOR PERFORMANCE |
4 | 0.0000131291 | GLYCOPROTEIN VI//GPVI//CLEC 2 |
5 | 0.0000124753 | CARDIOVASC INFECT GRP//ALBERT A ALKEK BIOSCI TECHNOL//PLATELET MICROBICIDAL PROTEINS |
6 | 0.0000118954 | MICROPARTICLES//ENDOTHELIAL MICROPARTICLES//PLATELET DERIVED MICROPARTICLES |
7 | 0.0000098637 | NEUTROPHIL EXTRACELLULAR TRAPS//NEUTROPHIL EXTRACELLULAR TRAP//NETOSIS |
8 | 0.0000086333 | LYMPHOTACTIN//CTAP III//CHEMOKINE STRUCTURE |
9 | 0.0000085003 | PRIMA CLIN MED//BIOMED EVOLUT AGING//CLIN LIPID |
10 | 0.0000078670 | THROMBOCYTOSIS//TCIPA//TUMOR CELL INDUCED PLATELET AGGREGATION |